All type of patients: 11 trials - MENDEl 2 - DESCARTES - Mendel 1 - LAPLACE-TIMI 57 - GAUSS 1 - RUTHERFORD-1 - YUKAWA-1 - LAPLACE 2 - GAUSS 2 - RUTHERFORD-2 - FOURIER
| evolocumab vs | No demonstrated result | |
| evolocumab vs ezetimibe alone | No demonstrated result | |
| evolocumab vs placebo | No demonstrated result | |
| evolocumab vs placebo (on top statins) | cardiovascular events by 20% (fully demonstrated) suggested myocardial infarction (fatal and non fatal) by 27% (not demonstrated) suggested stroke (fatal and non fatal) by 21% (not demonstrated) |
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
